Vaughn Bryan T 4

What Happened
Vaughn Bryan T, Executive Vice President, Diagnostics at LabCorp (LH), had 323 restricted stock units (RSUs convertable to common shares) vest on Feb 11, 2026. To satisfy tax withholding, 93 of those shares were withheld at $289.89 per share (total withholding ≈ $26,960). The net result was 230 shares delivered to Mr. Bryan (323 vested − 93 withheld).

Key Details

• Transaction date: 2026-02-11 (reported on Form 4 filed 2026-02-13).
• Vesting/conversion: 323 RSUs converted to common stock (reported as derivative exercise/conversion, code M).
• Tax withholding: 93 shares withheld (code F) at $289.89/share; withholding value ≈ $26,960.
• Net shares issued to insider: 230 shares.
• Footnotes: F1 = each RSU equals one share; F2 = stock withheld to satisfy tax obligations; F3 = these RSUs are from a grant vesting in three equal annual installments beginning Feb 11, 2026; F4 = filing notes aggregate RSUs held by the reporting person.
• Filing timeliness: Report filed Feb 13, 2026 for a Feb 11 transaction (within the usual two-business-day Form 4 window).

Context
This was a routine vesting of compensation (RSUs) and a tax-withholding disposition — not an open-market sale or purchase. The withholding is effectively a non-cash sale to cover taxes; the remaining shares are retained by the insider. Such entries typically reflect compensation vesting rather than a directional trading signal.